| N-Fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase II and induce apoptosis in G1/S phase AT Baviskar, C Madaan, R Preet, P Mohapatra, V Jain, A Agarwal, ... Journal of medicinal chemistry, 2011 | 313 | 2011 |
| Dendrimer building toolkit: Model building and characterization of various dendrimer architectures PKM Vishal Maingi, Vaibhav Jain, Prasad V. Bharatam Journal of Computational Chemistry, 2012 | 122 | 2012 |
| Molecular dynamics simulations of PPI dendrimer–drug complexes V Jain, V Maingi, PK Maiti, PV Bharatam Soft Matter 9 (28), 6482-6496, 2013 | 58 | 2013 |
| Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs V Jain, PV Bharatam Nanoscale 6 (5), 2476-2501, 2014 | 54 | 2014 |
| 5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair … D Das, R Preet, P Mohapatra, SR Satapathy, S Siddharth, T Tamir, V Jain, ... DNA repair 24, 15-25, 2014 | 50 | 2014 |
| Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents N Sanghai, V Jain, R Preet, S Kandekar, S Das, N Trivedi, P Mohapatra, ... MedChemComm 5 (6), 766-782, 2014 | 46 | 2014 |
| Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases S Basu, DA Barawkar, V Ramdas, M Patel, Y Waman, A Panmand, ... European journal of medicinal chemistry 134, 218-229, 2017 | 38 | 2017 |
| Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis S Abbat, V Jain, PV Bharatam Journal of Biomolecular Structure and Dynamics 33 (9), 1913-1928, 2015 | 33 | 2015 |
| Identification of Druggable Targets for Acinetobacter baumannii Via Subtractive Genomics and Plausible Inhibitors for MurA and MurB N Kaur, M Khokhar, V Jain, PV Bharatam, R Sandhir, R Tewari Applied Biochemistry and Biotechnology, 1-20, 2013 | 31 | 2013 |
| Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations V Jain, PK Maiti, PV Bharatam The Journal of Chemical Physics 145 (12), 2016 | 22 | 2016 |
| Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia AM Deshpande, D Bhuniya, S De, B Dave, VP Vyavahare, SH Kurhade, ... European journal of medicinal chemistry 133, 268-286, 2017 | 21 | 2017 |
| Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation S Basu, DA Barawkar, S Thorat, YD Shejul, M Patel, M Naykodi, V Jain, ... Journal of Medicinal Chemistry 60 (2), 681-694, 2017 | 21 | 2017 |
| Structural Elaboration of a Natural Product: Identification of 3, 3′‐Diindolylmethane Aminophosphonate and Urea Derivatives as Potent Anticancer Agents S Kandekar, R Preet, M Kashyap, RP MU, P Mohapatra, D Das, ... ChemMedChem 8 (11), 1873-1884, 2013 | 19 | 2013 |
| Molecular modelling and QSAR analysis of some structurally diverse N-type calcium channel blockers J Mungalpara, A Pandey, V Jain, CG Mohan Journal of molecular modeling 16, 629-644, 2010 | 17 | 2010 |
| Rational design, synthesis, and structure–activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors S Basu, P Prathipati, S Thorat, S Ansari, M Patel, V Jain, RR Jinugu, ... Bioorganic & Medicinal Chemistry 25 (1), 67-74, 2017 | 16 | 2017 |
| Synthesis, biological evaluation, and molecular modeling studies of novel heterocyclic compounds as anti-proliferative agents A Chaudhary, PP Sharma, G Bhardwaj, V Jain, PV Bharatam, ... Medicinal Chemistry Research, 1-16, 2013 | 15 | 2013 |
| Uridine monophosphate kinase as potential target for tuberculosis: From target to lead identification A Arvind, V Jain, P Saravanan, CG Mohan Interdisciplinary Sciences: Computational Life Sciences 5 (4), 296-311, 2013 | 12 | 2013 |
| 3-Formylchromone Based Topoisomerase IIα Inhibitors: Discovery of Potent Leads S Singh, AT Baviskar, V Jain, N Mishra, UC Banerjee, PV Bharatam, ... Med. Chem. Commun., 2013 | 12 | 2013 |
| Conformational polymorphism in bicalutamide: a quantum chemical study DK Dhaked, V Jain, Y Kasetti, PV Bharatam Structural Chemistry, 2012 | 11 | 2012 |
| First Pharmacophore Model of CCR3 Receptor Antagonists and its Homology Model‐Assisted, Stepwise Virtual Screening V Jain, P Saravanan, A Arvind, CG Mohan Chemical biology & drug design 77 (5), 373-387, 2011 | 11 | 2011 |
Purusottam MohapatraClinical Research Centre, Translational Medicine, Lund University, Malmö, SwedenVerified email at med.lu.se
